Compounds > 1-hexadecyl-2-acetyl-glycero-3-phosphocholine
Page last updated: 2024-09-02

1-hexadecyl-2-acetyl-glycero-3-phosphocholine and trandolapril

1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with trandolapril in 1 studies

Compound Research Comparison

Studies
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)		Trials
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)		Recent Studies (post-2010)
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)		Studies
(trandolapril)		Trials
(trandolapril)		Recent Studies (post-2010) (trandolapril)
9,15618755254121471

Protein Interaction Comparison

ProteinTaxonomy1-hexadecyl-2-acetyl-glycero-3-phosphocholine (IC50)trandolapril (IC50)
Angiotensin-converting enzyme Homo sapiens (human)0.0009

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Brown, NL; Fichelle, J; Jouquey, S; Worcel, M1

Other Studies

1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and trandolapril

ArticleYear
Comparison of the effects of the ace inhibitors trandolapril and enalapril on phlogogen induced foot pad oedema in the rat.
    Agents and actions, 1988, Volume: 24, Issue:3-4

    Topics: Animals; Bradykinin; Carrageenan; Dextrans; Edema; Enalapril; Foot; Indoles; Male; Platelet Activating Factor; Rats; Rats, Inbred Strains

1988